Impax Laboratories, Inc. (IPXL)

1 member of Congress has disclosed 2 trades in Impax Laboratories, Inc. (IPXL) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 31 October 2017. Aggregate disclosed activity totals roughly $16K in purchases (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for IPXL
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for IPXL

2 transactions
Compliance: 0%
Josh Gottheimer31 Oct 201713 Aug 2018PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer31 Oct 201713 Aug 2018PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$0

Volume

3.01M

Beta

1.27

P/E Ratio

-10.11

Fundamentals

EPS

$-1.81

Div. Yield

-

Open

$18.20

Day Range

$17.40 – $18.95

Company Information

Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ · USD
Country
US
IPO Date
1995-12-19
Website
www.impaxlabs.com

Impax Laboratories, Inc. is a specialized pharmaceutical firm distinguished by its technological foundation. Its primary endeavors involve the research and development, production, and market introduction of precision drug delivery mechanisms, generi...

Earnings

Recent Quarters

Q3 201731 Dec
EPS$-1.81

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about IPXL

Which members of Congress have traded IPXL?
1 member of Congress has disclosed 2 trade in Impax Laboratories, Inc. (IPXL) under the STOCK Act: Josh Gottheimer.
When was IPXL most recently disclosed by Congress?
The most recent IPXL disclosure was a purchase by Josh Gottheimer on 31 October 2017.
What is the total disclosed congressional trading volume for IPXL?
Members of Congress have disclosed approximately $16K in IPXL purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in IPXL?
This IPXL page updates as soon as new STOCK Act disclosures are filed for Impax Laboratories, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.